Skip to content

Clinical trials

Epilepsy trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: Latvia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20063
20082
20102
20112
20121
20131
20141
20162
20171
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.6
Longboard Pharmaceuticals3
GlaxoSmithKline2
UCB BIOSCIENCES GmbH2
UCB BIOSCIENCES, Inc.2
UCB Pharma2
Eisai Co., Ltd.1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
UCB Biopharma S.P.R.L.1
Xenon Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy21
Seizures10
Neurodevelopmental Disorders3
Epilepsies, Myoclonic2
Lennox Gastaut Syndrome2
Epilepsies, Partial1

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.